ABMS Lifelong Learning CME Activity

Pharmacogenomics: From Your Patient’s Perspective

The same medications and treatments are not universally effective for every patient. As consumer knowledge of genetics increases, more patients will be coming to you with a direct-to-consumer (DTC) genetics test in hand. What expectations will your patients have? How…

Becoming a Better Prescriber: Introduction to Pharmacogenomics

The same medications and treatments are not universally effective for every patient. How do physicians better prescribe medication and treatments to patients? Is there a way to determine which medication will work better for a specific patient? This course will…

Pharmacogenomics: Tools and Technology

When sharing PGx information with patients and other health care providers, the electronic health record (EHR) can serve as an active or passive support for clinicians in addition to assisting in clinical decision making surrounding PGx. While there are benefits…

Pharmacogenomics: Building Institutional Support

Pharmacogenomics (or PGx) is a multidisciplinary aspect of health care that can provide more personalized treatment for patients. This approach to health care, while gaining interest at the provider level, requires the support of one’s institution to be a successful…

What We Know About Long-acting Injectable Antipsychotics Can Help Innovate HIV Care

Long-acting injectable antiretroviral therapy (LA-ART) is a powerful new addition to the treatments available for patients living with HIV, but broad acceptance and uptake could be compromised by what we know about patients’ and clinicians’ experiences with long-acting injectable antipsychotics…

Exceptionalism at the End of AIDS

HIV/AIDS exceptionalism promoted compassion, garnered funding, built institutions, and shaped regulatory and research agendas under emergency conditions. Globally, however, HIV/AIDS exceptionalism has further fragmented fragile health service delivery systems in vulnerable, marginalized communities and created perverse incentives to influence seropositive…

Is “Undetectable = Untransmissible” Good Public Health Messaging?

This article considers merits and drawbacks of “undetectable = untransmissible” (U = U) messaging in the global HIV response. First, viral suppression might be achieved with effective treatment, but not everyone living with HIV has access to such intervention and…

Ethics Talk: Chronic Emergency and the Limits of Peace-Time Bioethics

This activity is comprised of five multiple-choice questions based on the content of an AMA Journal of Ethics podcast about the rise of states of “chronic emergency,” how health care workers can be protected when working conflict zones, and how…